11,417 Shares in CVS Health Corporation $CVS Purchased by AGP Franklin LLC

AGP Franklin LLC bought a new stake in CVS Health Corporation (NYSE:CVS) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 11,417 shares of the pharmacy operator’s stock, valued at approximately $906,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. National Pension Service raised its position in shares of CVS Health by 3.1% during the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC grew its holdings in CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after buying an additional 79,340 shares during the last quarter. AE Wealth Management LLC increased its position in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after buying an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after acquiring an additional 22,653 shares during the last quarter. Finally, Alpha Omega Wealth Management LLC lifted its position in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CVS. Wolfe Research decreased their price target on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, March 2nd. Argus cut their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Leerink Partners restated an “outperform” rating and set a $98.00 target price on shares of CVS Health in a research report on Thursday, March 5th. TD Cowen reaffirmed a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Finally, Robert W. Baird boosted their price target on CVS Health from $92.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.05.

CVS Health Price Performance

CVS opened at $78.87 on Friday. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The company’s 50 day simple moving average is $76.03 and its 200 day simple moving average is $77.84. The stock has a market capitalization of $101.08 billion, a PE ratio of 57.15, a P/E/G ratio of 0.80 and a beta of 0.51. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue was up 8.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 7.14 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be issued a $0.665 dividend. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analyst / media bullishness: A feature arguing that CVS is an attractive value/turnaround stock highlights improving fundamentals and a clearer earnings outlook, which can support investor demand and valuation rerating. Is CVS Health the Ultimate Value Stock to Buy Right Now?
• Neutral Sentiment: Recent intraday / market movement: Coverage noting a recent pullback in CVS shares (about a 1.2% decline in the prior session) frames how short-term market flows and sector moves are influencing the name independent of fundamentals. Watch volume and whether buyers step in on weakness. CVS Health (CVS) Stock Falls Amid Market Uptick
• Negative Sentiment: State-level PBM crackdown: Tennessee passed a bill restricting pharmacy ownership of PBMs; CVS warns the law could force closures of many stores in the state and has signaled legal action. This creates near-term revenue and margin uncertainty in affected markets and raises the risk of similar laws elsewhere. Legislation to ban pharmacies from owning PBMs heads to Gov. Lee’s desk, CVS Health may close Tenn. locations
• Negative Sentiment: Broader regulatory threat: Coverage of a sweeping new healthcare law targeting parts of the drug supply chain suggests larger national policy risk that could force store closures or change CVS’s PBM economics; that elevates legal, operational and reimbursement uncertainty for investors. CVS fights law that could force over 100 stores to close
• Negative Sentiment: Deal cost risk for primary care expansion: Analysis of the Mass General Brigham–CVS primary care arrangement flags a potential ~$40M “hidden” access/cost issue, implying integration or access costs that could weigh on margins from the company’s care-delivery growth strategy. Mass General Brigham, CVS Primary Care Deal Could Have a $40M Hidden Cost of Access

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.